Canopy Growth Stock Is Setting Up for Long-Term Growth, But Will Investors Wait?

Canopy Growth (TSX:WEED) stock could eventually be the largest marijuana producer in the world, but that depends on a whole lot of “ifs.”

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy Growth (TSX:WEED) hasn’t had the best luck as of late in terms of share price. After reaching all-time highs around $70 per share, it seems the stock only had one way to go, and that was down. Now, shares continue to hit 52-week lows again and again.

Yet Canopy Growth stock claims that it has long-term plans that are set to make the stock soar. But the big question is whether investors will wait.

What are these plans?

The plans can really be summed up in one word: America.

Canopy Growth stock wants to be the largest producer of cannabis in the future largest consumer of cannabis in the world. That’s the United States. The problem is, the stuff isn’t even legal there yet. Well, not entirely.

States continue to legalize cannabis, at least for medical use, if not entirely for recreational use. And due to this continued process, Canopy Growth stock expects marijuana to become legal in the very near future.

The company wouldn’t be entirely offside to think so. It remains that as these states legalize cannabis, the White House continues to make attempts to decriminalize it. In fact, in recent months Canopy Growth stock climbed, as President Biden announced a pardon for those with simple marijuana possession.

This led to Canopy Growth stock taking a major step forward in their plans of U.S. domination. It went through with the acquisition of Acreage Holdings, which has a major set up across the country. It also continues to shut down production in Canada, showing that it’s serious about a U.S. set-up.

But is this the right move?

Created with Highcharts 11.4.3Canopy Growth PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

Investors don’t think so

Canopy Growth stock has made several moves on this side of the border that investors simply aren’t fans of. This included laying off 800 workers in recent month. That came after the company reported a $266.7 million net loss during the third quarter.

The marijuana market is highly competitive in Canada. But even with that competition, the company stated it would not be lowering prices anytime soon — even as the Ontario Cannabis Store decreased the margins it makes on weed sales.

Given the cost-cutting measures Canopy Growth stock has made in the last few years, it doesn’t come as a surprise. What’s more, the company looks like it will continue to make cost savings a priority, with profit high on the to-do list.

So, while cannabis operations in the U.S. could possibly save the company, it can’t come soon enough. Investors are now fearful that it will ever arrive. And should that be the case, even a major market like the U.S. may not be able to save Canopy Growth stock.

Bottom line

There are a lot of barriers in the way for Canopy Growth stock if it hopes to come out on top in the U.S. Yet the largest, of course, is profit. It has to be said that while it still operates at a loss, this has been a significant improvement over the last few years. The company continues to bring its debts lower and lower. This has been helped along from its investment into non-cannabis products, including the popular BioSteel.

Still, with shares down 75% in the last year, and dropping, Canopy Growth stock remains a risky stock that I would merely keep on your watchlist until legalization truly hits the U.S.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »